82 related articles for article (PubMed ID: 4059657)
1. Genetic toxicity of several antihypertensive drugs possessing a hydrazine group.
Kitamura J; Mori H; Sugie S; Kawai K
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):415-22. PubMed ID: 4059657
[TBL] [Abstract][Full Text] [Related]
2. Genetic effects of binazine and hydralazine in vitro and in vivo.
Chłopkiewicz B; Ejchart A; Marczewska J
Acta Pol Pharm; 1995; 52(1):31-3. PubMed ID: 8960236
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity and carcinogenicity studies of antihypertensive agents.
Brambilla G; Martelli A
Mutat Res; 2006 Mar; 612(2):115-49. PubMed ID: 16458045
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro genotoxicity of three antihypertensive hydrazine derivatives (hydralazine, dihydralazine, and endralazine).
de Flora S; Zanacchi P; Bennicelli C; Camoirano A; Cavanna M; Sciabà L; Cajelli E; Faggin P; Brambilla G
Environ Mutagen; 1982; 4(5):605-19. PubMed ID: 7140679
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of hydralazine induced mutagenicity and genotoxicity.
Chopkiewicz B; Ejchart A; Marczewska J
Acta Pol Pharm; 1995; 52(3):219-22. PubMed ID: 8960252
[TBL] [Abstract][Full Text] [Related]
6. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
Parodi S; De Flora S; Cavanna M; Pino A; Robbiano L; Bennicelli C; Brambilla G
Cancer Res; 1981 Apr; 41(4):1469-82. PubMed ID: 7214329
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of a variety of azobenzene and aminoazobenzene compounds in the hepatocyte/DNA repair test and the Salmonella/mutagenicity test.
Mori H; Mori Y; Sugie S; Yoshimi N; Takahashi M; Ni-i H; Yamazaki H; Toyoshi K; Williams GM
Cancer Res; 1986 Apr; 46(4 Pt 1):1654-8. PubMed ID: 3081253
[TBL] [Abstract][Full Text] [Related]
8. Genotoxicity of the antihypertensive drugs hydralazine and dihydralazine.
Williams GM; Mazue G; McQueen CA; Shimada T
Science; 1980 Oct; 210(4467):329-30. PubMed ID: 7423193
[TBL] [Abstract][Full Text] [Related]
9. Acetylation and its role in the mutagenicity of the antihypertensive agent hydralazine.
Lemke LE; McQueen CA
Drug Metab Dispos; 1995 May; 23(5):559-65. PubMed ID: 7587931
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and general pharmacological properties of budralazine.
Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity of a variety of hydrazine derivatives in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes.
Mori H; Sugie S; Yoshimi N; Iwata H; Nishikawa A; Matsukubo K; Shimizu H; Hirono I
Jpn J Cancer Res; 1988 Feb; 79(2):204-11. PubMed ID: 3130355
[TBL] [Abstract][Full Text] [Related]
12. Comparative 90-day toxicity of two decarboxylase inhibitors, benserazide and carbidopa, in the rat.
Rauws AG; Vos JG; Garbis-Berkvens JM; Peters PW; de Vries T; van Logten MJ
Toxicol Appl Pharmacol; 1982 Nov; 66(2):201-20. PubMed ID: 7164099
[No Abstract] [Full Text] [Related]
13. Mutagenicity of hydralazine in mammalian cells and bacteria.
McQueen CA; Way BM; Queener SM
Toxicol Appl Pharmacol; 1993 Jan; 118(1):135-8. PubMed ID: 8430421
[TBL] [Abstract][Full Text] [Related]
14. Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
Shibamura S; Chiba T; Suzuki I; Akashi A
Arzneimittelforschung; 1981; 31(7):1076-9. PubMed ID: 6268123
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mutagenic activity of hydralazine and dihydralazine in Salmonella typhimurium strains differing in expression of antioxidant genes.
Chłopkiewicz B
Toxicol Lett; 1999 Nov; 110(3):203-7. PubMed ID: 10597029
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydrazine, phenelzine, and hydralazine treatment on rat hepatic and renal drug-metabolizing enzyme expression.
Runge-Morris M; Feng Y; Zangar RC; Novak RF
Drug Metab Dispos; 1996 Jul; 24(7):734-7. PubMed ID: 8818569
[TBL] [Abstract][Full Text] [Related]
17. Genotoxicity of hydrazino-phtalazine antihypertensive drugs assessed by an in vitro micronucleus assay.
Chłopkiewicz B
Acta Pol Pharm; 1996; 53(5):361-4. PubMed ID: 9415211
[TBL] [Abstract][Full Text] [Related]
18. Species variation in the genotoxicity of batracylin.
Stevens GJ; McQueen CA
Toxicol Appl Pharmacol; 1994 May; 126(1):39-44. PubMed ID: 8184431
[TBL] [Abstract][Full Text] [Related]
19. Relationship between oxidative metabolites of hydrazine and hydrazine-induced mutagenicity.
Noda A; Ishizawa M; Ohno K; Sendo T; Noda H
Toxicol Lett; 1986 May; 31(2):131-7. PubMed ID: 3520960
[TBL] [Abstract][Full Text] [Related]
20. [Mutagenicity of alkylnitrites in the Salmonella test].
Quinto I
Boll Soc Ital Biol Sper; 1980 Apr; 56(8):816-20. PubMed ID: 7004467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
